Principal Investigators

Aliza P. Wingo, M.D., M.Sc.

[NCBI Bibliography]

Dr. Wingo is an Assistant Professor of Psychiatry at Emory University and Physician-Scientist at the Atlanta Veterans Administration Medical Center. She received her Medical Degree and a Master of Science in Clinical Research from Emory University where she also completed her residency training in Psychiatry. During her career development award, Dr. Wingo acquired advanced statistical and bioinformatic skills for association mapping of complex phenotypes using genome-wide genotyping, transcriptomes, and microRNA profiles.

Thomas S. Wingo, M.D.

[NCBI Bibliography] [Google Scholar] [GitHub]

Dr. Wingo is an Assistant Professor of Neurology and Human Genetics at Emory University and Physician-Scientist at the Atlanta Veterans Administration Medical Center. His primary lab is at the Center for Neurodegenerative Disease in the Whitehead building on Emory’s main campus. He has post-doctoral training in statistical genetics, next-generation sequencing, and bioinformatics. He is a board certified neurologist with fellowship training in cognitive neurology and see patients at the Atlanta VAMC Cognitive Center of Excellence. Dr. Wingo is a member of the Population Biology Evolution and Ecology Graduate Program at Emory University.

Research Staff

Wen Fan, MS.

Wen graduated from Duke University with a Master degree in biostatistics and received her B.S. degree in plant genetics at University of Florida. Wen has a diverse background in bioinformatics and biostatistics. Her research work at Duke included: 1) meta-analysis in lung cancer clinical trials; 2) longitudinal data analysis; and 3) time series data analysis. Wen joins the Wingo lab in 2018 as a biostatistician.

Ekaterina Gerasimov, PhD.

Dr. Gerasimov earned her doctoral degree in computer science at Georgia State University. She has comprehensive experience in bioinformatics and computational genomics and algorithms. Her general research interest at GSU was designing and applying advanced algorithms and statistical tools for analysis of next-generation sequencing data related to cancer and infection diseases. Dr. Gerasimov joined the Wingo lab in 2018 as an Assistant Scientist.

Adriana Lori, PhD.

Dr. Lori received her Ph.D. in Genetic Sciences at the University of Pisa (Italy). Her dissertation focused on identifying chromosomal damages in children exposed to Chernobyl fallout to estimate long-term effects of radiation to the genome. Dr. Lori’s current research involves the role of genetic and epigenetic mechanisms in the development of stress-related disorders and social behaviors. Dr. Lori has been one of the primary genetic investigators of the Grady Trauma Project involved in molecular and bioinformatics analyses of sequence variants, GWAS and whole genome sequencing. Dr. Lori joins the Wingo lab in November 2018 as a Research Associate.

Melissa Armendariz, B.S.

Ms. Armendariz graduated from Virginia Tech with a B.S. in Biochemistry and a minor in Chemistry and Psychology. She is a research coordinator who joined the Wingo lab in 2016. She collects, synthesizes, and manages clinical and genetic data to identify new genetic causes of Alzheimer’s disease.

Se Min (Minnie) Canon, B.S.

Minnie first joined the Wingo Lab as an Undergraduate Research Assistant in Fall of 2012. She went on to do a Senior Project on the genetic causes of an early-onset Alzheimer’s disease case in a family from Colombia. After graduating from Emory University (B.S. in Neuroscience and Behavioral Biology), she joined the lab as a Research Specialist in 2014. She continues to work on family-based genetic studies of Alzheimer’s disease

Post-Doctoral Fellows

Chloe Robins, PhD.

Dr. Robins received her PhD from the Population Biology, Ecology, and Evolution Graduate Program at Emory University. Her doctoral work used statistical genetic methods to investigate the evolutionary basis of human aging. She joined the Wingo Lab after graduation, and is now working on identifying epigenetic and proteomic changes associated with Alzheimer’s Disease.

Alex Kotlar, PhD

Dr. Kotlar received his Ph.D. in Genetics at Emory University in 2018. His work was the development of online services (such as https://bystro.io) that assisted researchers in analyzing terabytes of genomic data, decreasing analysis times by an order of magnitude. He joined the Wingo Lab to develop next-generation online proteomics services

Graduate Students

Ha Eun Kong, B.S.

Ms. Kong is an M.D./Ph.D. student in Genetics and Molecular Biology Graduate Program who co-mentored by Drs. Peng Jin and Thomas Wingo. The focus of her work is to identify new genetic modifiers of Fragile X Tremor Ataxia Syndrome and causes of Alzheimer’s disease.

Collaborators

David Bennett, M.D.

[NCBI Bibliography] Dr. Bennett is the Director of the Rush Alzheimer’s Disease Core Center and Principal Investigator of the Rush Memory and Aging Project. Dr. Bennett is an internationally known Alzheimer’s disease researcher.

Patricia Boyle, Ph.D.

[NCBI Bibliography] Dr. Boyle is a neuropsychologist with the Rush Alzheimer’s Disease Center and professor in the Department of Behavioral Sciences. Her primary interest is the prevention of age-related cognitive and functional decline and dementia.

David Cutler, Ph.D.

[NCBI Bibliography] Dr. Cutler is a population and statistical geneticist, talented programmer, and collaborates with us on family- and population-based studies of Alzheimer’s disease. His own work focuses on mapping, base-calling, and deep thinking about the problems of next-generation sequencing and statistical genetics.

Greg Gibson, Ph.D.

[NCBI Bibliography] Dr. Gibson is a Professor in the School of Biology at Georgia Tech. He obtained his PhD in genetics at the University of Basel and completed a Post-Doc training at Stanford. Dr. Gibson’s research focuses on how transcriptome profiling can be used to understand more about the genetic basis of complex traits and disease susceptibility.

Chadwick Hales, M.D., Ph.D.

[NCBI Bibliography] Dr. Hales is a neurocognitive neurologist, neuroscientist, molecular biologist, and electrophysiologist. His major focus is to understand pathological accumulation of proteins in traumatic brain injury and neurodegenerative disease.

Peng Jin, Ph.D.

[NCBI Bibliography] Dr. Jin is a geneticist interested in trinucleotide repeat disorders, microRNA, and methylation and epigenetic changes as they related to neurodegenerative illnesses. He is particularly interested in Fragile-X associated tremor-ataxia syndrome and G4C2 expanded repeats in C9Orf72 implicated in amyotrophic lateral sclerosis and frontotemporal dementia.

James Lah, M.D., Ph.D.

[NCBI Bibliography] Dr. Lah is a cognitive neurologist, Clinical Director of the Emory Alzheimer’s disease Research Center, and the vice-chair for the Emory University Department of Neurology. His interests include in RNA splicing and using proteomics to understand the pathogenesis of Alzheimer’s disease.

Allan I. Levey, M.D., Ph.D.

[NCBI Bibliography] Dr. Levey is a Chair of the Emory University Department of Neurology, Director of the Emory Alzheimer’s Disease Research Center, cognitive neurologist, and neuroscientist/neuroanatomist.

Benjamin Logsdon, Ph.D.

[NCBI Bibliography] Dr. Logsdon received his PhD in Computational Biology at Cornell University and post-doctoral training in statistical genetics and genome sciences at the Fred Hutchinson Cancer Research Center and University of Washington. Dr. Logsdon is a senior scientist at Sage Bionetworks.

Kerry Ressler, M.D., Ph.D.

[NCBI Bibliography] Dr. Ressler is chief scientific officer and James and Patricia Poitras Chair in Psychiatry at McLean Hospital. Dr. Ressler’s lab focuses on translational research bridging molecular neurobiology in animal models with human genetic research on emotion, particularly fear and anxiety disorders. Dr. Ressler has been mentor for Dr. Aliza Wingo on her career development award and continues to collaborate with her on different projects.

Nicholas Seyfried, DPhil.

[NCBI Bibliography] Dr. Seyfried is a biochemist and proteomics expert. He and Dr. Thomas Wingo lead a project that focuses on understanding genes identified in Alzheimer’s Disease genome-wide association studies may contribute to pathologic accumulation of aggregated proteins (NIH Reporter).

Jingjing Yang, Ph.D.

Dr. Yang is an assistant professor of the Center for Computational and Quantitative Genetics affiliated with the Department of Human Genetics, Emory University School of Medicine. Dr. Yang is a statistical geneticist mainly working on developing statistical and computational methods for mapping complex traits and diseases, particularly focusing on integrative analysis of multi-level OMICS data.

Alumni

Maohua Xie, PhD

Dr. Xie received his Master Degree in Analytics at Georgia State University and PhD in Biochemistry and Molecular Biology at Wuhan University, China. Previously he worked as a Cancer researcher and published over 15 research articles in journals including Cancer Cell, and Nature Communications. After he obtained his Analytics degree, he joined the Wingo lab and worked as a Bioinformatician. He is working on using genomic and proteomic (i.e., proteogenomic) approaches to identify novel genetic variants related to AD.

Eleanor A. Sharp, B.S.

Ms. Sharp examined patterns of Inheritance among families with Early-onset Alzheimer’s Disease with Dr. Wingo as a student in the SURE program in 2012. She is currently a medical student at the University of Virginia School of Medicine.

Stephanie Stennett, M.A.

Ms. Stennett joined the Wingo Lab in 2013 as a research coordinator and led Dr. Aliza Wingo’s Genome-wide Association Study of Resilience before she moved to Texas to work for a private company.

Brittney Innocente, B.A.

Ms. Innocente joined the Wingo Lab in 2015 as a research coordinator and led Dr. Aliza Wingo’s Genome-wide Association Study of Resilience until its completion in 2016.

Zoe White, B.S.

Ms. White is a senior research technician who joined the Wingo Lab in 2012. She performs targeted capture and next-generation sequencing experiments to identify new genetic causes of Alzheimer’s Disease.